Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort.
Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort.
复制标题
DOI:
10.3899/jrheum.130874
复制
发表时间:
2014-04
期刊:
影响因子:
--
通讯作者:
Greenlee RT
中科院分区:
文献类型:
--
作者:
Bartels CM;Buhr KA;Goldberg JW;Bell CL;Visekruna M;Nekkanti S;Greenlee RT
To examine the mortality and cardiovascular disease (CVD) burden among a population-based cohort of patients with systemic lupus erythematosus (SLE) with previously described late mean onset and low rates of organ-threatening disease. This retrospective population-based cohort study investigated incident cases of SLE diagnosed from 1991–2008 and followed through March 2009 to examine rates of death and CVD events: myocardial infarction, stroke, or congestive heart failure hospitalization. Cases were identified using the 1997 update of 1982 American College of Rheumatology SLE criteria. Searches included electronic records, chart audits, and state death matches, with physician review. Age and sex-matched population comparisons facilitated relative event rate calculations. 70 incident SLE cases had late mean onset (52 years), with an incidence of 5 cases per 100,000/year. Matched comparisons showed similar baseline rates of hypertension, hyperlipidemia, and diabetes. However, SLE patients experienced more CVD in the 2 years preceding SLE diagnosis, odds ratio 3.8 (95% CI 1.8, 8.0). The estimated 10-year mortality rates were 26% for SLE subjects versus 19% for comparisons, hazard ratio (HR) 2.1, p<0.01. Adjusted for prior CVD, SLE cases still demonstrated increased hazards of mortality (HR 1.9, p=0.01) and CVD event or death (HR 1.8, p=0.01). This incident SLE cohort demonstrated approximately doubled mortality and CVD event hazards compared to age and sex-matched comparisons, even after accounting for higher CVD events in the 2 years preceding SLE diagnosis. This raises future research questions regarding delayed lupus diagnosis versus accelerated CVD prior to SLE, particularly in older-onset SLE.
登录
查看更多内容
影响因子:
5
作者:
Magder, Laurence S.;Petri, Michelle
通讯作者:
Petri, Michelle
影响因子:
3
作者:
Larson, SL;Fleishman, JA
通讯作者:
Fleishman, JA
影响因子:
1.4
作者:
Borzecki, AM;Wong, AT;Berlowitz, DR
通讯作者:
Berlowitz, DR
影响因子:
4.7
作者:
Lim, S. Sam;Drenkard, Cristina;Somers, Emily C.
通讯作者:
Somers, Emily C.
影响因子:
3.9
作者:
Lalani, Sheliza;Pope, Janet;Peschken, Christine
通讯作者:
Peschken, Christine